{
    "nctId": "NCT05860621",
    "briefTitle": "Promoting Physical Activity in Breast Cancer Survivors on Aromatase Inhibitors",
    "officialTitle": "Promoting Physical Activity Through Supervised vs Motivational Behavior Change Interventions in Breast Cancer Survivors on Aromatase Inhibitors (PAC-WOMAN): A 3-arm Pragmatic Randomized Controlled Trial",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer Female, Hormone-receptor-positive Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 122,
    "primaryOutcomeMeasure": "Change from baseline in Physical activity on Actigraph GT9X accelerometers at 16 months",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. post-menopausal women, below 70 years old;\n2. histologically confirmed hormone-receptor-positive breast cancer (stage I, II, III);\n3. having initiated aromatase inhibitor hormonal therapy following the primary treatment (surgery, radiotherapy, chemotherapy, etc.), at least 1 month before being enrolled;\n4. ECOG-Performance Status 0-1.\n\nExclusion Criteria:\n\n1. evidence of stage IV cancer or synchronous tumors;\n2. uncontrolled hypertension, cardiac or pulmonary disease;\n3. contraindications to exercise training according to the assistant doctor;\n4. inability to provide informed consent;\n5. expected inability to fulfill the proposed schedule.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}